Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood-tests during long-term treatment: cohort study using data from Clinical Practice Research Datalink Gold and Aurum.
Georgina NakaferoMatthew J GraingeTim CardMaarten W TaalGuruprasad P AithalWeiya ZhangMichael DohertyChristopher P FoxChristian D MallenAbhishek AbhishekPublished in: Rheumatology (Oxford, England) (2021)
We have developed and externally validated an easy-to-use prognostic model that may be used to risk-stratify monitoring for leflunomide toxicity and to make informed choices about risks when choosing treatments.